Dehnavi, P., Rakhshandeh, H., Bakhtiari, E., Asadpour, H., Moshirian Farahi, S
It is not intended for human ingestion, medical, diagnostic, or veterinary use
Although aging is an inevitable, natural process of every living organism, people continue searching for that miracle pill that will preserve their youth
Top 20 Companies in Global Glucagon-Like Peptide-1 Agonists Market (20262035): Expert View By Spherical Insights RELEASE DATE: May 2026 Author: Spherical Insights According to a research report published by Spherical Insights & Consulting, The Global Glucagon-Like Peptide-1 Agonists Market size is projected to grow from USD 46.18 Billion in 2025 to USD 160.42 Billion by 2035, at a CAGR of 13.28% during the forecast period 20262035
Several GLP-1 agonists have demonstrated cardiovascular benefits in clinical trials, including reductions in major adverse cardiovascular events (MACE) such as heart attack, stroke, and cardiovascular death